ReadiUse™ 4% formaldehyde fixation solution
Ordering information
Price | |
Catalog Number | |
Unit Size | |
Quantity |
Additional ordering information
Telephone | 1-800-990-8053 |
Fax | 1-800-609-2943 |
sales@aatbio.com | |
International | See distributors |
Bulk request | Inquire |
Custom size | Inquire |
Shipping | Standard overnight for United States, inquire for international |
Storage, safety and handling
H-phrase | H303, H313, H333 |
Hazard symbol | XN |
Intended use | Research Use Only (RUO) |
R-phrase | R20, R21, R22 |
Storage | Refrigerated (2-8 °C); Minimize light exposure |
UNSPSC | 12352200 |
Related products
Overview | ![]() ![]() |
See also: Buffers and Lab Consumables
All our ReadiUse™ reagents require minimal hands-on time. This 4% formaldehyde solution is a ready-to-apply format. It is widely used for fixing cells in fluorescence imaging applications.
Images
![F-actin stain of CPA cells.<br />CPA cells were fixed with ReadiUse™ 4% formaldehyde fixation solution (Cat#20010) and then stained with Cell Navigator® F-Actin Labeling Kit (cat#22661). A: label with 1X iFluor® 488-phalloidin for 30 min only. B: Treat the cells with phalloidin for 10 min, then stain them with 1X iFluor® 488-phalloidin for 30 min. ](/_next/image?url=https%3A%2F%2Fimages.aatbio.com%2Fproducts%2Ffigures-and-data%2Freadiuse-4-percent-formaldehyde-fixation-solution%2Ffigure-for-readiuse-4-percent-formaldehyde-fixation-solution_pIzm4.jpg&w=3840&q=75)
Figure 1. F-actin stain of CPA cells.
CPA cells were fixed with ReadiUse™ 4% formaldehyde fixation solution (Cat#20010) and then stained with Cell Navigator® F-Actin Labeling Kit (cat#22661). A: label with 1X iFluor® 488-phalloidin for 30 min only. B: Treat the cells with phalloidin for 10 min, then stain them with 1X iFluor® 488-phalloidin for 30 min.
CPA cells were fixed with ReadiUse™ 4% formaldehyde fixation solution (Cat#20010) and then stained with Cell Navigator® F-Actin Labeling Kit (cat#22661). A: label with 1X iFluor® 488-phalloidin for 30 min only. B: Treat the cells with phalloidin for 10 min, then stain them with 1X iFluor® 488-phalloidin for 30 min.
![Expressions of NSE, O4 and GFAP in the experimental groups indicating NSC differentiation by fluorescence microscopy (×100). NSCs were fixed in ReadiUse™ 4% formaldehyde fixation solution (AAT Bioquest, CA, USA) for 15–20 min at room temperature, and then permeabilized with 1% (vol/vol) Triton X-100 (Invitrogen; Thermo Fisher Scientific, Inc.) in phosphate-buffered saline (PBS; Hyclone; GE Healthcare Life Sciences) for 30 min, and incubated in blocking buffer which contained 10% goat serum (Biorbyt, Cambridge, UK) for 10 min. Immunofluorescence staining performed simultaneously on each group, red (CY3) represents the expression NSE or O4 in cytoplasm, green (FITC) represents the expression of GFAP in cytoplasm, blue (Hoechst 33258) represents the nucleus. NSC, neural stem cell; NSE, enolase 2; GFAP, glial fibrillary acidic protein; O4, oligodendrocyte cell surface antigen O4; CON, blank control group; NC, negative control plasmid-transfected cells; N, normal brain tissue; HIBD, hypoxic-ischemic brain damage tissue; siNSC, β-catenin small interfering RNA-transfected cells. Source: <b>Impact of siRNA targeting of β-catenin on differentiation of rat neural stem cells and gene expression of Ngn1 and BMP4 following in vitro hypoxic-ischemic brain damage</b> by Zhang, Xiaoying et.al., <em>Molecular Medicine Reports</em>, Aug. 2016](/_next/image?url=https%3A%2F%2Fimages.aatbio.com%2Fproducts%2Ffigures-and-data%2Freadiuse-4-percent-formaldehyde-fixation-solution%2Ffigure-for-readiuse-4-percent-formaldehyde-fixation-solution_YglG1.jpeg&w=3840&q=75)
Figure 2. Expressions of NSE, O4 and GFAP in the experimental groups indicating NSC differentiation by fluorescence microscopy (×100). NSCs were fixed in ReadiUse™ 4% formaldehyde fixation solution (AAT Bioquest, CA, USA) for 15–20 min at room temperature, and then permeabilized with 1% (vol/vol) Triton X-100 (Invitrogen; Thermo Fisher Scientific, Inc.) in phosphate-buffered saline (PBS; Hyclone; GE Healthcare Life Sciences) for 30 min, and incubated in blocking buffer which contained 10% goat serum (Biorbyt, Cambridge, UK) for 10 min. Immunofluorescence staining performed simultaneously on each group, red (CY3) represents the expression NSE or O4 in cytoplasm, green (FITC) represents the expression of GFAP in cytoplasm, blue (Hoechst 33258) represents the nucleus. NSC, neural stem cell; NSE, enolase 2; GFAP, glial fibrillary acidic protein; O4, oligodendrocyte cell surface antigen O4; CON, blank control group; NC, negative control plasmid-transfected cells; N, normal brain tissue; HIBD, hypoxic-ischemic brain damage tissue; siNSC, β-catenin small interfering RNA-transfected cells. Source: Impact of siRNA targeting of β-catenin on differentiation of rat neural stem cells and gene expression of Ngn1 and BMP4 following in vitro hypoxic-ischemic brain damage by Zhang, Xiaoying et.al., Molecular Medicine Reports, Aug. 2016
Citations
View all 4 citations: Citation Explorer
Rhinacanthin C Alleviates Amyloid-β Fibrils' Toxicity on Neurons and Attenuates Neuroinflammation Triggered by LPS, Amyloid-β, and Interferon-γ in Glial Cells
Authors: Chuang, Kai-An and Li, Ming-Han and Lin, Ni-Hsuan and Chang, Chih-Hsuan and Lu, I and Pan, I and Takahashi, Tomoya and Perng, Ming-Der and Wen, Shu-Fang and others, undefined
Journal: Oxidative Medicine and Cellular Longevity (2017)
Authors: Chuang, Kai-An and Li, Ming-Han and Lin, Ni-Hsuan and Chang, Chih-Hsuan and Lu, I and Pan, I and Takahashi, Tomoya and Perng, Ming-Der and Wen, Shu-Fang and others, undefined
Journal: Oxidative Medicine and Cellular Longevity (2017)
Impact of siRNA targeting of β-catenin on differentiation of rat neural stem cells and gene expression of Ngn1 and BMP4 following in vitro hypoxic-ischemic brain damage
Authors: Zhang, Xiaoying and Zhu, Cuicui and Luo, Qiong and Dong, Jv and Liu, Lv and Li, Min and Zhu, Hongtao and Ma, Xiangping and Wang, Jun
Journal: Molecular Medicine Reports (2016): 3595--3601
Authors: Zhang, Xiaoying and Zhu, Cuicui and Luo, Qiong and Dong, Jv and Liu, Lv and Li, Min and Zhu, Hongtao and Ma, Xiangping and Wang, Jun
Journal: Molecular Medicine Reports (2016): 3595--3601
Application of interleukin-22 mediates protection in experimental acetaminophen-induced acute liver injury
Authors: Scheiermann, Patrick and Bachmann, Malte and Goren, Itamar and Zwissler, Bernhard and Pfeilschifter, Josef and Mühl, Heiko
Journal: The American journal of pathology (2013): 1107--1113
Authors: Scheiermann, Patrick and Bachmann, Malte and Goren, Itamar and Zwissler, Bernhard and Pfeilschifter, Josef and Mühl, Heiko
Journal: The American journal of pathology (2013): 1107--1113
Synergistic activity of αvβ3 integrins and the elastin binding protein enhance cell-matrix interactions on bioactive hydrogel surfaces
Authors: Patel, Dhaval and V, undefined and romme, Susan E and Reid, Michael E and Taite, Lakeshia J
Journal: Biomacromolecules (2012): 1420--1428
Authors: Patel, Dhaval and V, undefined and romme, Susan E and Reid, Michael E and Taite, Lakeshia J
Journal: Biomacromolecules (2012): 1420--1428
References
View all 122 references: Citation Explorer
Concept of a selective tumour therapy and its evaluation by near-infrared fluorescence imaging and flat-panel volume computed tomography in mice
Authors: Alves F, Dullin C, Napp J, Missbach-Guentner J, Jannasch K, Mathejczyk J, Pardo LA, Stuhmer W, Tietze LF.
Journal: Eur J Radiol (2009): 286
Authors: Alves F, Dullin C, Napp J, Missbach-Guentner J, Jannasch K, Mathejczyk J, Pardo LA, Stuhmer W, Tietze LF.
Journal: Eur J Radiol (2009): 286
Multiplexed fluorescence imaging of tumor biomarkers in gene expression and protein levels for personalized and predictive medicine
Authors: Smith MQ, Staley CA, Kooby DA, Styblo T, Wood WC, Yang L.
Journal: Curr Mol Med (2009): 1017
Authors: Smith MQ, Staley CA, Kooby DA, Styblo T, Wood WC, Yang L.
Journal: Curr Mol Med (2009): 1017
In vivo fluorescence imaging: a personal perspective
Authors: Ghoroghchian PP, Therien MJ, Hammer DA.
Journal: Wiley Interdiscip Rev Nanomed Nanobiotechnol (2009): 156
Authors: Ghoroghchian PP, Therien MJ, Hammer DA.
Journal: Wiley Interdiscip Rev Nanomed Nanobiotechnol (2009): 156
Clinical implications of near-infrared fluorescence imaging in cancer
Authors: Kosaka N, Ogawa M, Choyke PL, Kobayashi H.
Journal: Future Oncol (2009): 1501
Authors: Kosaka N, Ogawa M, Choyke PL, Kobayashi H.
Journal: Future Oncol (2009): 1501
Biosensors technologies: acousto-optic tunable filter-based hyperspectral and polarization imagers for fluorescence and spectroscopic imaging
Authors: Gupta N., undefined
Journal: Methods Mol Biol (2009): 293
Authors: Gupta N., undefined
Journal: Methods Mol Biol (2009): 293
Transcranial flavoprotein fluorescence imaging of mouse cortical activity and plasticity
Authors: Tohmi M, Takahashi K, Kubota Y, Hishida R, Shibuki K.
Journal: J Neurochem (2009): 3
Authors: Tohmi M, Takahashi K, Kubota Y, Hishida R, Shibuki K.
Journal: J Neurochem (2009): 3
Fluorescence lifetime and polarization-resolved imaging in cell biology
Authors: Levitt JA, Matthews DR, Ameer-Beg SM, Suhling K.
Journal: Curr Opin Biotechnol (2009): 28
Authors: Levitt JA, Matthews DR, Ameer-Beg SM, Suhling K.
Journal: Curr Opin Biotechnol (2009): 28
Fluorescence lifetime imaging microscopy (FLIM) in biological and medical research
Authors: Korczynski J, Wlodarczyk J.
Journal: Postepy Biochem (2009): 434
Authors: Korczynski J, Wlodarczyk J.
Journal: Postepy Biochem (2009): 434
Lymphatic imaging in humans with near-infrared fluorescence
Authors: Rasmussen JC, Tan IC, Marshall MV, Fife CE, Sevick-Muraca EM.
Journal: Curr Opin Biotechnol (2009): 74
Authors: Rasmussen JC, Tan IC, Marshall MV, Fife CE, Sevick-Muraca EM.
Journal: Curr Opin Biotechnol (2009): 74
Rational and precise design of novel fluorescence probes and their application to cellular response and in-vivo tumor imaging
Authors: Urano Y., undefined
Journal: Tanpakushitsu Kakusan Koso (2009): 1344
Authors: Urano Y., undefined
Journal: Tanpakushitsu Kakusan Koso (2009): 1344